Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Endo Health Solutions Inc    ENDP   US29264F2056

Real-time Quote. Real-time BATS US - 05/17 04:59:59 pm
34.375 USD   +3.20%
6d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
6d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
05/10 ENDO HEALTH SOLUTIONS INC: Endo Health Solutions Responds to FDA's Denial ..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Endo Health Solutions Inc : JOHNSON MATTHEY PLC - Director/PDMR Shareholding

06/29/2012| 06:40am US/Eastern
Recommend:
0

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND CONNECTED PERSONS

1.        Name of the issuer:                                                  
                                                                               
          Johnson Matthey plc                                                  
                                                                               
2.        State whether the notification relates to (i) a transaction notified 
          in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance 
          with LR 9.8.6R(1) or (iii) a disclosure made in accordance with      
          section 793 of the Companies Act (2006):                             
                                                                               
          In accordance with DTR 3.1.2R                                        
                                                                               
3.        Name of person discharging managerial responsibilities/director:     
                                                                               
          G P Otterman                                                         
                                                                               
4.        State whether notification relates to a person connected with a      
          person discharging managerial responsibilities/director named in 3   
          and identify the connected person:                                   
                                                                               
          Notification relates to person named in 3 above                      
                                                                               
5.        Indicate whether the notification is in respect of a holding of the  
          person referred to in 3 or 4 above or in respect of a non-beneficial 
          interest:                                                            
                                                                               
          Notification is in respect of a holding of the person named in 3     
          above                                                                
                                                                               
6.        Description of shares (including class), debentures or derivatives or
          financial instruments relating to shares:                            
                                                                               
          Ordinary Shares of £1 each                                           
                                                                               
7.        Name of registered shareholders(s) and, if more than one, the number 
          of shares held by each of them:                                      
                                                                               
          G P Otterman                                                         
                                                                               
8.        State the nature of the transaction:                                 
                                                                               
          Exercise of executive share options and subsequent disposal of       
          shares. Details are as follows:                                      

          Ordinary Shares  Date          Exercise    Number     Sale Price 
          under option     of Grant      Price (£)   Disposed   (£)        
                                                                               
          6,688            17 July 2002  8.65        6,688      21.26681   

9.        Number of shares, debentures or financial instruments relating to   
          shares acquired:                                                    
                                                                               
          See 8 above                                                         
                                                                               
10.       Percentage of issued class acquired (treasury shares of that class  
          should not be taken into account when calculating percentage):      
                                                                               
          N/A                                                                 
                                                                               
11.       Number of shares, debentures or financial instruments relating to   
          shares disposed:                                                    
                                                                               
          See 8 above                                                         
                                                                               
12.       Percentage of issued class disposed (treasury shares of that class  
          should not be taken into account when calculating percentage):      
                                                                               
          Less than 0.1%                                                      
                                                                               
13.       Price per share or value of transaction:                            
                                                                               
          See 8 above                                                         
                                                                               
14.       Date and place of transaction:                                      
                                                                               
          28 June 2012, London                                                
                                                                               
15.       Total holding following notification and total percentage holding   
          following notification (any treasury shares of that class should not
          be taken into account when calculating percentage):                 
                                                                               
          N/A                                                                 
                                                                               
16.       Date issuer informed of transaction:                                
                                                                               
          29 June 2012, London                                                
                                                                               

Name and signature of duly authorised officer of issuer responsible for making notification


Angela Purtill

Deputy Company Secretary
Date of Notification

29 June 2012

Recommend :
0
Partner Area
React to this article
 
Latest news on ENDO HEALTH SOLUTIONS INC
6d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
6d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
05/10 ENDO HEALTH SOLUTIONS INC: Endo Health Solutions Responds to FDA's Denial of OP..
05/07DJEndo Health Swings to First-Quarter Profit On Strong Generic Drug Sales
04/15 ENDO HEALTH SOLUTIONS INC: Endo to Announce First Quarter 2013 Financial Result..
03/05 ENDO HEALTH SOLUTIONS INC: Endo Health Solutions to Present at the Cowen and Co..
03/01DJU.S. HOT STOCK FUTURES: Hot stocks to watch
02/28DJEndo Health Swings to Surprise 4th-Quarter Loss Amid Big Write-Down
02/25 ENDO HEALTH SOLUTIONS INC: Rajiv De Silva Named President and CEO of Endo Healt..
02/13 ENDO HEALTH SOLUTIONS INC: Endo to Announce Fourth Quarter 2012 Financial Resul..
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.